--- title: "Hot ‘N’ Cold: Decoding Glioblastoma’s Complex Immune Landscape" description: Advanced preclinical modeling systems, comprehensive molecular characterization, and AI is transforming GBM immunotherapy development approaches. image: https://whitepapers.certisoncology.com/hubfs/intracranial-inoculation-and-inhibition-via-MRI-optimized.png --- [![CERTIS](https://whitepapers.certisoncology.com/hubfs/certis-lockup-horz-color.svg "CERTIS")](https://www.certisoncology.com/) - [Home](https://www.certisoncology.com/) - Drug Developers - [CertisAI™️](https://www.certisoncology.com/for-drug-developers/predictive-oncology-intelligence/) - [Cancer Models](https://www.certisoncology.com/for-drug-developers/cancer-models-preclinical-studies/) - [Custom Models](https://www.certisoncology.com/for-drug-developers/custom-model-development/) - [In Vitro/Ex Vivo](https://www.certisoncology.com/for-drug-developers/in-vitro-ex-vivo-pharmacology/) - [In Vivo](https://www.certisoncology.com/for-drug-developers/in-vivo-pharmacology/) - [Imaging/Endpoints](https://www.certisoncology.com/for-drug-developers/imaging-endpoint-analysis/) - [Immuno-Oncology](https://www.certisoncology.com/for-drug-developers/immuno-oncology/) - Oncologists - [Order YourPDX®](https://www.certisoncology.com/for-oncologists/order-yourpdx/) - [Clinical Research](https://www.certisoncology.com/for-oncologists/clinical-research/) - [Patient Education](https://www.certisoncology.com/for-oncologists/patient-education/) - About - [Mission, Vision & Values](https://www.certisoncology.com/about-us/mission-vision-values/) - [Team](https://www.certisoncology.com/about-us/our-team/) - [Our Story](https://www.certisoncology.com/about-us/our-story/) - [Careers](https://www.certisoncology.com/about-us/careers/) - [Company News](https://www.certisoncology.com/about-us/news/) - [Contact Us](https://www.certisoncology.com/contact-us/) - Resource Library - [Cancer Facts](https://www.certisoncology.com/resources/cancer-market-facts/) - [Clinical Results](https://www.certisoncology.com/resources/clinical-results/) - [Supporting Research](https://www.certisoncology.com/resources/supporting-research/) - [Media](https://www.certisoncology.com/resources/media/) - [White Papers](https://news.certisoncology.com/) - [Contact](https://www.certisoncology.com/contact-us/) [Database Login](https://oncointel.certisoncology.com) ![CTA_KRAS-CertiScreen-824x424-1-720x424](https://whitepapers.certisoncology.com/hs-fs/hubfs/CTA_KRAS-CertiScreen-824x424-1-720x424.jpg?width=720&name=CTA_KRAS-CertiScreen-824x424-1-720x424.jpg "CTA_KRAS-CertiScreen-824x424-1-720x424") ### VALIDATE YOUR KRAS-TARGETING STRATEGY Combining Predictive AI + Advanced Cancer Models to Help Direct Oncology Drug Development and Clinic Research Studies. [LEARN MORE](https://www.certisoncology.com/kras-targeted-oncology-drug-development/) - [Home](https://www.certisoncology.com/) - Drug Developers - Drug Developers - [CertisAI™️](https://www.certisoncology.com/for-drug-developers/predictive-oncology-intelligence/) - [Cancer Models](https://www.certisoncology.com/for-drug-developers/cancer-models-preclinical-studies/) - [Custom Models](https://www.certisoncology.com/for-drug-developers/custom-model-development/) - [In Vitro/Ex Vivo](https://www.certisoncology.com/for-drug-developers/in-vitro-ex-vivo-pharmacology/) - [In Vivo](https://www.certisoncology.com/for-drug-developers/in-vivo-pharmacology/) - [Imaging/Endpoints](https://www.certisoncology.com/for-drug-developers/imaging-endpoint-analysis/) - [Immuno-Oncology](https://www.certisoncology.com/for-drug-developers/immuno-oncology/) - Oncologists - Oncologists - [Order YourPDX®](https://www.certisoncology.com/for-oncologists/order-yourpdx/) - [Clinical Research](https://www.certisoncology.com/for-oncologists/clinical-research/) - [Patient Education](https://www.certisoncology.com/for-oncologists/patient-education/) - About - About - [Mission, Vision & Values](https://www.certisoncology.com/about-us/mission-vision-values/) - [Team](https://www.certisoncology.com/about-us/our-team/) - [Our Story](https://www.certisoncology.com/about-us/our-story/) - [Careers](https://www.certisoncology.com/about-us/careers/) - [Company News](https://www.certisoncology.com/about-us/news/) - [Contact Us](https://www.certisoncology.com/contact-us/) - Resource Library - Resource Library - [Cancer Facts](https://www.certisoncology.com/resources/cancer-market-facts/) - [Clinical Results](https://www.certisoncology.com/resources/clinical-results/) - [Supporting Research](https://www.certisoncology.com/resources/supporting-research/) - [Media](https://www.certisoncology.com/resources/media/) - [White Papers](https://news.certisoncology.com/) - [Contact](https://www.certisoncology.com/contact-us/) ![CTA_KRAS-CertiScreen-824x424-1-720x424](https://whitepapers.certisoncology.com/hs-fs/hubfs/CTA_KRAS-CertiScreen-824x424-1-720x424.jpg?width=720&name=CTA_KRAS-CertiScreen-824x424-1-720x424.jpg "CTA_KRAS-CertiScreen-824x424-1-720x424") ### VALIDATE YOUR KRAS-TARGETING STRATEGY Combining Predictive AI + Advanced Cancer Models to Help Direct Oncology Drug Development and Clinic Research Studies. [LEARN MORE](https://www.certisoncology.com/kras-targeted-oncology-drug-development/) - [Cancer Facts](https://www.certisoncology.com/resources/cancer-market-facts/) - [Clinical Results](https://www.certisoncology.com/resources/clinical-results/) - [Supporting Research](https://www.certisoncology.com/resources/supporting-research/) - [Media](https://www.certisoncology.com/resources/media/) - [White Papers](https://news.certisoncology.com) # Hot ‘N’ Cold: Decoding Glioblastoma’s Complex Immune Landscape ### An Integrated Preclinical Platform for GBM Immunotherapy Development This white paper presents a strategic platform for leveraging patient-derived xenografts, humanized models, and predictive technologies to identify, optimize, and translate promising immunotherapeutic strategies. By integrating tumor mutational burden analysis, HLA profiling, and multi-modal endpoint assessment, researchers can design rational combination therapies that address GBM’s complex immune landscape with unprecedented precision.   ![flowcytometry_stemcellmarkers](https://whitepapers.certisoncology.com/hs-fs/hubfs/flowcytometry_stemcellmarkers.webp?width=572&height=246&name=flowcytometry_stemcellmarkers.webp)   ### Download White Paper   [Back to Feed](https://blog.certisoncology.com) ### Share This ![Certis](https://whitepapers.certisoncology.com/hubfs/certis-logo-lockup-white.svg "Certis") 5626 Oberlin Drive, Suite 110 San Diego, CA 92121 Drug Development: 858-988-1033 Patients & Oncologists: 858-228-4110 Main: 858-952-1820 - #### Drug Developers - [CertisAI™](https://www.certisoncology.com/for-drug-developers/predictive-oncology-intelligence) - [Cancer Models](https://www.certisoncology.com/for-drug-developers/cancer-models-preclinical-studies) - [Custom Model Development](https://www.certisoncology.com/for-drug-developers/custom-model-development) - [In Vitro/Ex Vivo Pharmacology](https://www.certisoncology.com/for-drug-developers/in-vitro-ex-vivo-pharmacology) - [In Vivo Pharmacology](https://www.certisoncology.com/for-drug-developers/in-vivo-pharmacology) - [Imaging/Endpoint Analysis](https://www.certisoncology.com/for-drug-developers/imaging-endpoint-analysis) - [Immuno-Oncology](https://www.certisoncology.com/for-drug-developers/immuno-oncology/) - #### Oncologists - [Order YourPDX®](https://www.certisoncology.com/for-oncologists/order-yourpdx/) - [Clinical Research](https://www.certisoncology.com/for-oncologists/clinical-research/) - [Patient Education](https://www.certisoncology.com/for-oncologists/patient-education/) - #### Resource Library - [Cancer Facts](https://www.certisoncology.com/resources/cancer-market-facts) - [Clinical Results](https://www.certisoncology.com/resources/clinical-results) - [Supporting Research](https://www.certisoncology.com/resources/supporting-research) - [Media](https://www.certisoncology.com/resources/media) - [White Papers](https://news.certisoncology.com/) - #### About - [Mission, Vision & Values](https://www.certisoncology.com/about-us/mission-vision-values) - [Team](https://www.certisoncology.com/about-us/our-team) - [Our Story](https://www.certisoncology.com/about-us/our-story) - [Careers](https://www.certisoncology.com/about-us/careers) - [Company News](https://www.certisoncology.com/about-us/news/) - [Contact Us](https://www.certisoncology.com/contact-us) - [Login](https://oncointel.certisoncology.com) - [Privacy Policy](https://www.certisoncology.com/privacy-policy) - [![](https://whitepapers.certisoncology.com/hubfs/social-media--facebook.svg)](https://www.facebook.com/CertisOncology) - [![](https://whitepapers.certisoncology.com/hubfs/social-media--linkedin.svg)](https://www.linkedin.com/company/certis-oncology) - [![](https://whitepapers.certisoncology.com/hubfs/social-media--twitter.svg)](https://twitter.com/CertisOncology) - [![](https://whitepapers.certisoncology.com/hubfs/social-media--instagram.svg)](https://www.instagram.com/certis_oncology) - [![](https://whitepapers.certisoncology.com/hubfs/social-media--youtube.svg)](https://www.youtube.com/channel/UCeX4_jh3RlNKxQxZ89_utjg) - [![](https://whitepapers.certisoncology.com/hubfs/social-media--blog.svg)](https://blog.certisoncology.com/) ![certis-footer-mouse](https://whitepapers.certisoncology.com/hubfs/certis-footer-mouse.svg "certis-footer-mouse") --- ©2024 Certis Oncology Solutions. All rights reserved. Testimonials appearing on this site reflect real-life experiences of those who have used our services. To protect their privacy, photos feature models. ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Julie Genther", "url" : "https://whitepapers.certisoncology.com/author/julie-genther" }, "dateModified" : "2026-01-22T21:31:48.508Z", "datePublished" : "2026-01-20T12:15:00.000Z", "headline" : "Hot ‘N’ Cold: Decoding Glioblastoma’s Complex Immune Landscape", "image" : [ "https://whitepapers.certisoncology.com/hubfs/intracranial-inoculation-and-inhibition-via-MRI-optimized.png" ], "mainEntityOfPage" : { "@id" : "https://whitepapers.certisoncology.com/hot-n-cold-decoding-glioblastomas-complex-immune-landscape", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://whitepapers.certisoncology.com/hubfs/certis-logo-lockup_sig-1.png" }, "name" : "Certis Oncology Solutions" } } ```